BMS 181448

Drug Profile

BMS 181448

Alternative Names: LumenHance

Latest Information Update: 03 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ImaRx Therapeutics
  • Class Acetates; Amino acids; Biopolymers; Contrast media; Disaccharides; Inorganic chemicals
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Gastrointestinal disorders

Most Recent Events

  • 31 Dec 1999 Launched for Gastrointestinal disorders (diagnosis) in Central Europe (PO)
  • 31 Dec 1999 Launched for Gastrointestinal disorders (diagnosis) in Germany (PO)
  • 13 Feb 1998 Information has been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top